April 1, 2004
Running Time: 00:47:36
To bolster the U.S. Food and Drug Administration's ability to evaluate the safety of dietary supplements, a new report from the Institute of Medicine and the National Research Council of the National Academies outlines a science-based process for assessing supplement ingredients, even when data about a substance's safety in humans is scarce. This approach to safety evaluation works within the regulatory parameters set by the Dietary Supplement Health and Education Act (DSHEA), which does not require manufacturers to provide safety data on their products. However, supplement makers, the public, and others need to increase their reporting of health problems related to supplement use in order to further improve the agency's ability to protect consumers, the report says.
Barbara O. Schneeman, Ph.D. (chair),
Associate Vice Provost, University Outreach, and
Professor of Nutrition,
Department of Nutrition and
Division of Clinical Nutrition and Metabolism,
University of California Davis.